<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">NS</journal-id><journal-title-group><journal-title>Natural Science</journal-title></journal-title-group><issn pub-type="epub">2150-4091</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ns.2015.76036</article-id><article-id pub-id-type="publisher-id">NS-57203</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Chemistry&amp;Materials Science</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject></subj-group></article-categories><title-group><article-title>
 
 
  Analysis of 1246 Cases of Orbital Lesions: A Study of 17 Years
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>sad</surname><given-names>Aslam Khan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Suhail</surname><given-names>Sarwar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>M.</surname><given-names>Ali Ayaz Sadiq</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Munib</surname><given-names>Ur Rehman</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Asad</surname><given-names>Ullah</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Imran</surname><given-names>Ahmad</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Institute of Ophthalmology, King Edward Medical University, Mayo Hospital, Lahore, Pakistan</addr-line></aff><pub-date pub-type="epub"><day>27</day><month>05</month><year>2015</year></pub-date><volume>07</volume><issue>06</issue><fpage>324</fpage><lpage>337</lpage><history><date date-type="received"><day>30</day>	<month>April</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>14</month>	<year>June</year>	</date><date date-type="accepted"><day>17</day>	<month>June</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Purpose: The aim of this study is to present an analysis of orbital lesions by classifying them according to the site of origin in patients of all ages presenting at a tertiary care eye hospital from 1996 till 2012. Methods: 1637 patients were initially enrolled in this descriptive case series. Clinical data of 1246 patients who completed the study during 17 years were analyzed. Orbital lesions of the patients were examined and managed medically or surgically as per requirement. The histopathological reports of these patients were used to classify the lesions. Results: Out of all cases 54.57% (n = 680) were neoplastic and 45.42% (n = 566) were nonneoplastic lesions. Amongst the neoplastic lesions 86.17% (n = 586) were malignant and 13.82% (n = 94) were benign. Primary orbital lesions were the most common orbital lesions being 963 (77.29%) followed by secondary orbital lesions being 232 (18.62%), hematopoietic reticuloendothelial being 47 (3.77%) and metastatic lesions being 04 (0.32%). Conclusion: Orbital lesions are more common in adults as compared to children. Neoplastic lesions are more common than nonneoplastic lesions, and amongst the neoplastic lesions malignant lesions are more common than benign ones. Primary orbital lesions are the most common orbital lesions followed by secondary orbital lesions, lesions of the hematopoietic reticuloendothelial system and metastatic lesions.
 
</p></abstract><kwd-group><kwd>Neoplastic Lesions</kwd><kwd> Primary Orbital Lesions</kwd><kwd> Secondary Orbital Lesions</kwd><kwd> Hematopoietic Orbital  Lesions</kwd><kwd> Metastatic Orbital Lesions</kwd><kwd> Case Study</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The orbit, a four-sided pyramidal bony space in the skull, measures approximately 45 ml in an adult human. It houses the eyeball along with the ocular adnexa and comprises structures derived from all three germinal layers (ectodermal, mesodermal &amp; endodermal) as well as all the tissues (skin, muscle, connective tissue etc.) in the human body. Therefore it is not surprising that a pathology arising from any of these structures can contribute to the etiology of orbital lesions. But occasionally the orbit is affected by systemic diseases or secondarily by a disorder arising somewhere else in the body. The orbit is surrounded by, and is connected through various foramina and fissures to cranial cavity, nasal cavity and paranasal sinuses; hence diseases arising from the neighborhood can easily infiltrate the orbit and vice versa. The orbit is extensively connected to neuro-vascular system of face, head, neck and brain (particularly dural venous sinuses) and the pathologies of the orbit especially tumors spread quickly via hematogenous route in addition to local spread. True lymphatics have not been found in the orbit but involvement of regional lymph nodes by inflammatory or neoplastic lesion (probably along venous channels) has also been well documented [<xref ref-type="bibr" rid="scirp.57203-ref1">1</xref>] .</p><p>Orbital lesions can be classified in many ways depending upon tissue of origin (histological, histopathological or embryonal), anatomical site (eyeball, lacrimal gland, eyelids etc.), and clinical course (acute, chronic etc.). One of the commonest and useful classifications is Primary, Secondary &amp; Metastatic according to the site of origin [<xref ref-type="bibr" rid="scirp.57203-ref2">2</xref>] . The orbital contents include eyeball, optic nerve, main trunks/branches of arteries, veins, and cranial nerves III to VI, lacrimal gland, extraocular muscles, smooth muscles, orbital fat, ligaments, orbital fascia (including periorbita―the periosteal lining of orbit) and skin with its appendages [<xref ref-type="bibr" rid="scirp.57203-ref3">3</xref>] .<sup> </sup>Orbital lesions can occur in any age group or in either gender, but it has been observed that those arising at a younger age especially malignancies tend to behave more aggressively and an earlier diagnosis and prompt appropriate treatment can result in better prognosis [<xref ref-type="bibr" rid="scirp.57203-ref4">4</xref>] .</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>This descriptive case series was undertaken to analyze different orbital lesions presented during a period of 17 years. The subjects included those who visited Eye Department of Mayo Hospital Lahore, Pakistan during 17 years from 1996 till 2012. This study was undertaken in accordance with Declaration of Helsinki (1964 including its amendments) after approval from Ethical Committee of King Edward Medical University. Out of 1637 cases, 1246 cases of orbital lesions, who gave informed consent and completed the study with complete clinical records, were included in the analysis; the remaining 391 comprised those who left against the medical advice, were lost to follow up or never reported back after being referred/shifted to other departments like Otolaryngology, Neurosurgery or Oncology departments. After detailed history, examination and routine investigations, necessary investigations like Orbital/Ocular Ultrasonography (B Scan), X Ray Orbit/Paranasal sinuses/Cranium, CT scan and Magnetic Resonance Imaging (MRI) were performed. Surgery (usually orbitotomy) was performed when a definite space occupying lesion was identified during investigations. In some cases only biopsy was done to establish a histopathological diagnosis.</p></sec><sec id="s3"><title>3. Results</title><p>Out of 1246 patients, 57.46% (n = 716) were adults and 42.53% (n = 530) children. Out of all cases 54.57% (n = 680) were neoplastic and 45.42% (n = 566) nonneoplastic lesions. Amongst the neoplastic lesions 86.17% (n = 586) were malignant and 13.82% (n = 94) were benign. These lesions were divided into following four groups based on their site of origin:</p><p>&#167; Primary Orbital Lesions, which originated from the tissues of the orbit. Eye ball being a part of the orbit; therefore its lesions are included in the primary category.</p><p>&#167; Secondary Orbital Lesions, which originated from the adjacent structure like Eyelids, Paranasal sinuses, cranial cavity or nasopharynx and invaded the orbit secondarily.</p><p>&#167; Haematopoeitic Reticuloendothelial system lesions.</p><p>&#167; Metastatic, with primary in the distant organs.</p><p>Primary orbital lesions were the most common orbital lesions being 963 (77.29%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="table" rid="table1">Table 1</xref>) followed by secondary orbital lesions 232 (18.62%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="table" rid="table2">Table 2</xref>), hematopoietic reticuloendothelial 47 (3.77%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="table" rid="table3">Table 3</xref>) and metastatic 04 (0.32%) lesions (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="table" rid="table4">Table 4</xref>).</p><sec id="s3_1"><title>3.1. Primary Orbital Lesions</title><p>Amongst the primary orbital lesions, ocular lesions (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>) were most common 264 (27.41%)</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Percentage distribution of patients according to the type of orbital lesions</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x6.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Case of retinoblastoma with proptosis</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x7.png"/></fig><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Frequency and breakup of primary orbital lesions</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle"  colspan="4"  >PRIMARY ORBITAL LESIONS</th></tr></thead><tr><td align="center" valign="middle" >LESIONS</td><td align="center" valign="middle" >Frequency (n)</td><td align="center" valign="middle" >Proportion of primary Orbital lesions (%)</td><td align="center" valign="middle" >Proportion of total lesions (%)</td></tr><tr><td align="center" valign="middle" >Ocular Retinoblastoma Malignant melanoma Dysthyroid eye disease</td><td align="center" valign="middle" >264 251 12 01</td><td align="center" valign="middle" >27.41 26.06 01.25 00.1</td><td align="center" valign="middle" >21.18 20.14 00.96 00.08</td></tr><tr><td align="center" valign="middle" >Inflammatory Acute Orbital cellulitis Subperiosteal abscess Orbital abscess Epidural abscess Posttraumatic panophthalmitis Chronic Nonspecific Granulomatous Tuberculous Foreign body granuloma Giant cell Xanthogranuloma</td><td align="center" valign="middle" >173 29 13 07 01 01 56 33 25 04 03 01</td><td align="center" valign="middle" >17.96 3.01 1.35 0.73 00.1 00.1 5.81 3.43 2.60 0.42 0.31 00.1</td><td align="center" valign="middle" >13.88 02.32 01.04 00.56 00.08 00.08 04.49 02.65 02.00 00.32 00.24 00.08</td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle" >Cystic Dermoid cyst Epidermal cyst Hydatid cyst Lipodermoid cyst Hemorrhagic cyst Limbal dermoid Simple cyst Chocolate cyst Inflammatory cysts Hematic cyst Inclusion cyst</th><th align="center" valign="middle" >126 76 18 06 06 05 04 03 03 02 02 01</th><th align="center" valign="middle" >13.08 7.89 1.87 0.62 0.62 0.52 0.42 0.31 0.31 0.21 00.1 00.1</th><th align="center" valign="middle" >10.11 06.09 01.40 00.48 00.48 00.40 00.32 00.24 00.24 00.16 00.08 00.08</th></tr></thead><tr><td align="center" valign="middle" >Lacrimal gland lesions Adenocystic carcinoma Pleomorphic adenoma Lymphomas Tuberculosis Foreign body Miscellaneous Mikulicz syndrome Acinic cell tumours Mucoepidermoid carcinoma Lacrimal gland abscess Acute inflammation Lymphoepithelial proliferation</td><td align="center" valign="middle" >113 53 24 15 05 04 04 02 02 01 01 01 01</td><td align="center" valign="middle" >11.73 5.50 2.50 1.56 0.52 0.42 0.42 0.21 0.21 00.1 00.1 00.1 00.1</td><td align="center" valign="middle" >09.07 04.25 01.92 01.20 00.40 00.32 00.32 00.16 00.16 00.08 00.08 00.08 00.08</td></tr><tr><td align="center" valign="middle" >Vascular Cavernous hemangioma Capillary hemangioma Orbital varices Lymphangioma Malignant haemiangio pericytoma Pericytoma Carotid cavernous fistula Cavernous sinus fistula Cavernous sinus thrombosis Haemangioblastoma Malignant angioma A-V malformation</td><td align="center" valign="middle" >81 48 16 04 04 02 01 01 01 01 01 01 01</td><td align="center" valign="middle" >8.41 4.98 1.66 0.42 0.42 0.21 00.1 00.1 00.1 00.1 00.1 00.1 00.1</td><td align="center" valign="middle" >06.50 3.85 1.28 0.32 0.32 0.16 0.08 0.08 0.08 0.08 0.08 0.08 0.08</td></tr><tr><td align="center" valign="middle" >Optic nerve lesions Optic nerve glioma Meningioma</td><td align="center" valign="middle" >54 28 26</td><td align="center" valign="middle" >05.60 2.90 2.70</td><td align="center" valign="middle" >04.33 02.24 02.09</td></tr><tr><td align="center" valign="middle" >Pseudo tumor</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >04.67</td><td align="center" valign="middle" >03.61</td></tr><tr><td align="center" valign="middle" >Muscular Rhabdomyosarcoma Myositis</td><td align="center" valign="middle" >44 39 05</td><td align="center" valign="middle" >04.57 4.05 0.52</td><td align="center" valign="middle" >03.53 03.13 00.40</td></tr><tr><td align="center" valign="middle" >Nervous tissue related lesions Neurofibroma Schwanoma</td><td align="center" valign="middle" >35 25 10</td><td align="center" valign="middle" >03.63 2.60 1.03</td><td align="center" valign="middle" >02.81 2.01 00.80</td></tr><tr><td align="center" valign="middle" >Hyperthyroidism</td><td align="center" valign="middle" >08</td><td align="center" valign="middle" >00.83</td><td align="center" valign="middle" >00.64</td></tr><tr><td align="center" valign="middle" >Osseous Osteoma chronic Osteomyelitis Chronic osteomyelitis</td><td align="center" valign="middle" >08 04 03 01</td><td align="center" valign="middle" >00.83 0.42 0.31 00.1</td><td align="center" valign="middle" >00.64 00.32 00.24 00.08</td></tr><tr><td align="center" valign="middle" >Soft tissue sarcoma</td><td align="center" valign="middle" >06</td><td align="center" valign="middle" >00.62</td><td align="center" valign="middle" >00.48</td></tr><tr><td align="center" valign="middle" >Congenital lesions Encephalocoele Polycystic eye Heterotropic glial tissue</td><td align="center" valign="middle" >04 02 01 01</td><td align="center" valign="middle" >00.41 00.21 00.1 00.1</td><td align="center" valign="middle" >00.32 00.16 00.08 00.08</td></tr><tr><td align="center" valign="middle" >Histiocytoma</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >00.10</td><td align="center" valign="middle" >00.08</td></tr><tr><td align="center" valign="middle" >Fatty tissue</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >00.10</td><td align="center" valign="middle" >00.08</td></tr></tbody></table></table-wrap></table-wrap-group><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Retinoblastoma with fungating mass</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x8.png"/></fig><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Frequency &amp; break up of secondary orbital lesions</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="4"  >SECONDARY ORBITAL LESIONS</th></tr></thead><tr><td align="center" valign="middle" >LESIONS</td><td align="center" valign="middle" >Frequency (n)</td><td align="center" valign="middle" >Proportion of secondary orbital lesions (%)</td><td align="center" valign="middle" >Proportion of total lesions (%)</td></tr><tr><td align="center" valign="middle" >Eyelids Sq cell carcinoma Haemangioma Basal cell carcinoma Sebaceous cell carcinoma Malignant melanoma Malignant sebaceous cyst Adenocarcinoma</td><td align="center" valign="middle" >145 89 19 17 12 05 02 01</td><td align="center" valign="middle" >62.50 38.36 8.19 7.33 5.17 2.15 0.86 0.43</td><td align="center" valign="middle" >11.63 07.14 01.52 01.36 00.96 00.40 00.16 00.08</td></tr><tr><td align="center" valign="middle" >Paranasal sinuses Ethmoid sinus Ch ethmoiditis Orbital fracture Inverted papilloma Inflammed nasal polyp Ethmoidocele Frontal sinuses Frontocele Mucocele Pyocele Dacryocele Maxillary antrum Maxillary antum Carcinoma Ameloblastoma</td><td align="center" valign="middle" >86 43 02 01 01 01 01 08 08 01 18 02</td><td align="center" valign="middle" >37.07 18.53 0.86 0.43 0.43 0.43 0.43 3.45 3.45 0.43 7.76 0.86</td><td align="center" valign="middle" >06.90 03.45 00.16 00.08 00.08 00.08 00.08 00.64 00.64 00.08 01.44 00.16</td></tr><tr><td align="center" valign="middle" >Nasopharynx Nasopharyngeal fibroma</td><td align="center" valign="middle" >01 01</td><td align="center" valign="middle" >00.43 00.43</td><td align="center" valign="middle" >00.08 00.08</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Haematopoietic &amp; reticuloendothelial tissue lesions</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="4"  >HAEMATOPOIETIC RETICULOENDOTHELIAL</th></tr></thead><tr><td align="center" valign="middle" >LESIONS</td><td align="center" valign="middle" >Frequency (n)</td><td align="center" valign="middle" >Proportion of haematopoietic &amp; reticuloendothelial tissue lesions (%)</td><td align="center" valign="middle" >Proportion of total lesions (%)</td></tr><tr><td align="center" valign="middle" >Lymphoma/leukemia</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >93.62</td><td align="center" valign="middle" >03.53</td></tr><tr><td align="center" valign="middle" >Angiolymphoid hyperplasia</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >02.13</td><td align="center" valign="middle" >00.08</td></tr><tr><td align="center" valign="middle" >Plasmacytoma</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >02.13</td><td align="center" valign="middle" >00.08</td></tr><tr><td align="center" valign="middle" >Castleman’s disease</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >02.13</td><td align="center" valign="middle" >00.08</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Metastatic lesions</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="4"  >METASTATIC</th></tr></thead><tr><td align="center" valign="middle" >LESIONS</td><td align="center" valign="middle" >Frequency (n)</td><td align="center" valign="middle" >Proportion of metastatic lesions (%)</td><td align="center" valign="middle" >Proportion of total lesions (%)</td></tr><tr><td align="center" valign="middle" >Ewing sarcoma</td><td align="center" valign="middle" >03</td><td align="center" valign="middle" >75.00</td><td align="center" valign="middle" >00.24</td></tr><tr><td align="center" valign="middle" >Metastatic lesion of unknown origin</td><td align="center" valign="middle" >01</td><td align="center" valign="middle" >25.00</td><td align="center" valign="middle" >00.08</td></tr></tbody></table></table-wrap><p>(<xref ref-type="table" rid="table1">Table 1</xref>), followed by inflammatory 173 (17.96%) (<xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="fig" rid="fig5">Figure 5</xref>), cystic lesions 126 (13.08%) (<xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="fig" rid="fig7">Figure 7</xref>), lacrimal gland 113 (11.73%) (Figures 8-12), vascular 81 (8.41%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>3), optic nerve 54 (5.60%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>4), nervous tissue 35 (3.63%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>5), muscular 44 (4.57%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>6), pseudo tumor 45 (4.67%), hyperthyroidism 08 (0.83%), soft tissue sarcoma 06 (0.62%), osseous 08 (00.64%), congenital lesions 04 (0.41%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>7), histiocytoma 01 (0.10%) and fatty tissue 01 (0.10%) lesions.</p><p>1) Inflammatory lesions: Inflammatory lesions were mainly chronic 122 (70.5%) (<xref ref-type="fig" rid="fig5">Figure 5</xref>) and acute inflammation (29.5%) (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Chronic inflammations were non-specific 56 (32.37%), fungal granulomas 33 (19.07%), tuberculosis 25 (14.45%), foreign body granuloma 04 (2.31%), giant cell 03 (1.73%), and xantho- granuloma 01 (00.58%), whereas acute inflammatory lesions were orbital celluiitis 29 (16.76%), orbital abscess 07 (04.05%), sub-periosteal abscess 13 (7.51%), epidural abscess 01 (00.58%), post-traumatic panophthalmitis 01 (00.58%).</p><p>2) Ocular lesions: Among the ocular lesions 251 (95.07%) were Retinoblastoma (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>) and 12 (4.54%) were malignant melanoma.</p><p>3) Cystic lesions: Cystic lesions were mainly dermoid cyst 76 (60.32%) (<xref ref-type="fig" rid="fig6">Figure 6</xref>), epidermal cyst 18 (14.3%), hydatid cyst 6 (4.76%), lipodermoid cyst 6 (4.76%), hemorrhagic cyst 5 (3.97%), limbal dermoid 4 (3.17%), simple cyst 3 (2.38%), inflammatory cysts 2 (1.58%), hematic cyst 2 (1.58%) and Inclusion cyst 01 (0.79%).</p><p>4) Lacrimal gland lesions: Analysis of Lacrimal gland lesions revealed adenocystic carcinoma 53 (46.90%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>1), pleomorphic adenoma 24 (21.24%) (<xref ref-type="fig" rid="fig8">Figure 8</xref> and <xref ref-type="fig" rid="fig1">Figure 1</xref>0), lymphomas 15 (13.27%), tuberculosis 05 (4.42%), foreign body 04 (3.54%), miscellaneous 04 (3.54%), Mikulicz syndrome 02 (1.77%), acinic cell tumours 02 (1.77%), lacrimal gland abscess 01 (0.88%), acute inflammation 01 (0.88%) (<xref ref-type="fig" rid="fig4">Figure 4</xref>), lymphoepithelial 01 (0.88%) and mucoepidermoid carcinoma 01 (0.88%).</p><p>5) Vascular lesions: In the category of vascular lesions of the orbit, cavernous hemangioma 48 (59.25%) were the commonest followed by capillary hemangioma 16 (19.75%), orbital varices 04 (4.93%), lymphangioma 04 (4.93%), malignant haemiangio-pericytoma 02 (2.46%). pericytoma 01 (1.23%), carotid cavernous fistula 01 (1.23%), cavernous sinus fistula 01 (1.23%), canvernous sinus thrombosis 01 (1.23%), haemangioblastoms 01 (1.23%), malignant angioma 01 (1.23%) and A-V malformation 01 (1.23%) were the other less common lesions (<xref ref-type="fig" rid="fig1">Figure 1</xref>3).</p><p>6) Optic nerve lesions: Optic nerve lesions were mainly gliomas 28 (51.85%) and meningiomas 26 (48.15%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>4).</p><p>7) Nervous tissues lesions: Nervous tissues lesions comprises of neurofibroma 25 (71.42%) and schwanoma 10 (28.57%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>5).</p><p>8) Muscular lesions were mainly rhabdomyosarcoma 39 (88.63%) with 05 (11.36%) cases of myositis (<xref ref-type="fig" rid="fig1">Figure 1</xref>6).</p><p>9) Pseudotumors: These were seen in 45 (4.67%) cases of primary orbital lesions.</p><p>10) Osseous lesions: Osseous and bony tissue lesions comprise mainly of osteosarcomas 04 (50.0%), osteoma 03 (37.50) and chronic osteomyelitis 01 (12.50%) cases.</p><p>11) Congenital orbital lesions were encephalocoele 02 (50.00%), polycystic eye 01 (25.00%) and heterotropic glial tissue 01 (25.00%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>7).</p></sec><sec id="s3_2"><title>3.2. Secondary Orbital Lesions</title><p>Amongst the secondary orbital lesions, lesions of the eyelids were the commonest 145 (62.50%) followed by the lesions of paranasal sinuses 86 (37.07%) and nasopharynx 01 (00.43%) (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>1) Eyelid lesions: Amongst eyelid lesions squamous cell carcinoma was seen in 89 (61.38%) cases followed by basal cell carcinoma 17 (11.72%), haemangioma 19 (13.10%), sebaceous cell carcinoma 12 (8.28%), ma-</p><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Case of acute inflammation</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x9.png"/></fig><fig id="fig5"  position="float"><label><xref ref-type="fig" rid="fig5">Figure 5</xref></label><caption><title> Case of non-specific chronic inflammation</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x10.png"/></fig><fig id="fig6"  position="float"><label><xref ref-type="fig" rid="fig6">Figure 6</xref></label><caption><title> Case of dermoid cyst</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x11.png"/></fig><fig id="fig7"  position="float"><label><xref ref-type="fig" rid="fig7">Figure 7</xref></label><caption><title> B-Scan showing cystic lesion in superolateral orbit</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x12.png"/></fig><fig id="fig8"  position="float"><label><xref ref-type="fig" rid="fig8">Figure 8</xref></label><caption><title> Case of pleomorphic adenoma of lacrimal gland</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x13.png"/></fig><fig id="fig9"  position="float"><label><xref ref-type="fig" rid="fig9">Figure 9</xref></label><caption><title> CT scan showing mass along whole of roof of orbit</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x14.png"/></fig><fig id="fig10"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref>0</label><caption><title> Post operative case of pleomophic adenoma</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x15.png"/></fig><fig id="fig11"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref>1</label><caption><title> Case of adenocystic carcinoma of lacrimal gland</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x16.png"/></fig><fig id="fig12"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref>2</label><caption><title> Adenocystic carcinoma of lacrimal gland (tumor removed after lateral orbitotomy)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x17.png"/></fig><fig id="fig13"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref>3</label><caption><title> (a) Preoperative photo of a case of cavernous haemangioma of orbit; (b) B scan; (c) CT scan and (d) Tumour removed after lateral orbitotomy</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x18.png"/></fig><fig id="fig14"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref>4</label><caption><title> (a) Preoperative picture of meningioma of the optic nerve; (b) CT scan; (c) B scan of the orbit</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x19.png"/></fig><fig id="fig15"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref>5</label><caption><title> (a) Preoperative picture of a case of schwanoma; (b) CT scan and (c) and (d) Tumour removed after lateral orbitotomy</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x20.png"/></fig><fig id="fig16"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref>6</label><caption><title> Case of rhabdomyosarcoma</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x21.png"/></fig><fig id="fig17"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref>7</label><caption><title> Case of encephalocoele</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x22.png"/></fig><p>lignant melanoma 05 (3.45%), malignant sebaceous cyst 02 (1.38%), and adenocarcinoma of meibomian gland 01 (00.69%) (<xref ref-type="fig" rid="fig1">Figure 1</xref>8 and <xref ref-type="fig" rid="fig1">Figure 1</xref>9).</p><p>2) Paranasal sinuses: Ethmoidal lesions were the commonest amongst the lesions of paranasal sinuses 48/87 (49.42%) followed by lesions of the maxillary antrum 20/87 (23%) and frontal sinus lesions 18/87(20.69%). chronic ethmoditis was seen in 43 (89.58%) of cases of ethmoidal lesions, followed by 02 (4.17%) cases of orbital fracture and 01 (2.08%) case each of inverted papilloma, inflamed nasal polyp and ethmoidocele. Maxillary antrum carcinoma was seen in 18 (90.00%) case and ameloblastoma in 02 (10.00%) cases with lesions of maxillary antrum. Amongst lesions of frontal sinus 08 (44.44%) were frontocoele, 08 (44.44%) mucocele and 02 (11.12%) of pyocoele (<xref ref-type="fig" rid="fig2">Figure 2</xref>0 and <xref ref-type="fig" rid="fig2">Figure 2</xref>1).</p><p>3) There was only one case of nasopharyngeal fibroma seen in the series (<xref ref-type="fig" rid="fig2">Figure 2</xref>2).</p></sec><sec id="s3_3"><title>3.3. Haematopoetic &amp; Reticuloendothelial Lesions</title><p>Amongst the haematopoetic reticuloendothelial lesions, lymphoma/leukemia 44 (93.62%) were the commonest followed by angiolymphoid hyperplasia 01 (2.13%), plasmacytoma 01 (2.13%) and castleman’s disease 01 (2.13%) (Figures 23-26; <xref ref-type="table" rid="table3">Table 3</xref>).</p></sec><sec id="s3_4"><title>3.4. Metastatic Lesions</title><p>Amongst the 04 metastatic lesions, 03 (75.0%) were the Ewing Sarcomas and in 01 (25.0%) case primary lesion could not be identified (<xref ref-type="table" rid="table4">Table 4</xref>).</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>Orbital lesions can be derived from the structures located in the orbit or from the structures surrounding it. Sometimes a distant lesion such as a malignant tumour somewhere else in the body may seed into it. The most common mode of presentation is displacement of the eyeball or proptosis particularly if the lesion is intra-conal. The displacement could be axial (strictly forwards) or non-axial (upwards or downwards in addition to forward displacement). Other presentations could take the form of a palpable tumour which may become a fungating mass if tumour is malignant and sufficient time has elapsed.</p><fig id="fig18"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref>8</label><caption><title> Case of squamous cell carcinoma of eyelid</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x23.png"/></fig><fig id="fig19"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref>9</label><caption><title> Case of malignant melanoma of eye lid</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x24.png"/></fig><fig id="fig20"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref>0</label><caption><title> (a) Case of ethmoidocoele; (b) CT scan showing ethmoidocoele</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x25.png"/></fig><fig id="fig21"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref>1</label><caption><title> Mucocoele of the frontal sinus causing proptosis</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x26.png"/></fig><fig id="fig22"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref>2</label><caption><title> (a) Case of nasopharyngeal fibroma; (b) CT scan showing propotosis</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x27.png"/></fig><fig id="fig23"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref>3</label><caption><title> Case of lymphoma of the orbit presenting with proptosis</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x28.png"/></fig><fig id="fig24"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref>4</label><caption><title> CT scan of the case of lymphoma of the orbit</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x29.png"/></fig><fig id="fig25"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref>5</label><caption><title> Case of leukemia who presented with proptosis with corneal abscess</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x30.png"/></fig><fig id="fig26"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref>6</label><caption><title> CT scan of the patient with leukemia showing mass in the retrobulbar area</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/5-8302584x31.png"/></fig><p>The current study has revealed that orbital lesions are more common in adults 57.46% (n = 716) as compared to children 42.53% (n = 530). Parashkevova found similar distribution according to age in her patients and found that majority (61%) of patients presented in the sixth and the seventh decade [<xref ref-type="bibr" rid="scirp.57203-ref5">5</xref>] .<sup> </sup></p><p>In our study it was found that neoplastic lesions 54.57% (n = 680) are common than non neoplastic lesions 45.42% (n = 566) and amongst the neoplastic lesions, malignant lesions 86.17% (n = 586) are more common than benign 13.82% (n = 94). Demirci found similar results where malignant tumors were more common than benign tumors. Out of all cases, 63% presented with malignancy and 27% were benign [<xref ref-type="bibr" rid="scirp.57203-ref6">6</xref>] . Similar findings are also reported by Parashkevova who found 56% cases of malignant tumors and 44% cases of benign tumors over the period of 4 years [<xref ref-type="bibr" rid="scirp.57203-ref5">5</xref>] . In contrast to this, another study on analysis of space occupying lesions of orbit showed that out of the 2480 lesions, 1697 (68%) were benign and 783 (32%) were malignant. The most frequent benign tumors were dermoid cyst (14%) and cavernous hemangioma (9%). The most common malignant tumors were non-Hodgkin lymphoma (12%), basal cell carcinoma (3%), and orbital metastases (3%) [<xref ref-type="bibr" rid="scirp.57203-ref7">7</xref>] .<sup> </sup></p><p>Ohtsuka studied orbital tumors in Japanese patients over a period of 20 years and found that out of all patients, 89% were primary orbital tumors whereas 9% were secondary tumors originating from neighbouring areas of orbit and 2% were metastatic tumors [<xref ref-type="bibr" rid="scirp.57203-ref8">8</xref>] . These findings are well aligned with those of our study where Primary orbital lesions originating from the tissues of the orbit, including eyeball, are the most common orbital lesions followed by the secondary orbital lesions, originating from the adjacent structure (eyelids, paranasal sinuses, nasopharynx &amp; cranial cavity), lesions of the haemopoeitic reticuloendothelial system lesions and metastatic lesions. In 2008, a study conducted by Angotti-Neto reported similar results in 11-year histopathalogical analysis of orbital tumors. He found that out that of the studied 181 orbital space-occupying lesions, 70% were primary, 23% secondary, 6% metastatic and lymphomas, and 1% was not classified [<xref ref-type="bibr" rid="scirp.57203-ref9">9</xref>] .<sup> </sup></p></sec><sec id="s5"><title>5. Conclusions</title><p>Orbital lesions are more common in adults 57.46% (n = 716) as compared to children 42.53% (n = 530). Neoplastic lesions 54.57% (n = 680) are more common than nonneoplastic lesions 45.42% (n = 566), and amongst the neoplastic lesions, malignant lesions 86.17% (n = 586) are more common than benign 13.82% (n = 94). Primary orbital lesions originating from the tissues of the orbita, including eyeball, are the most common orbital lesions followed by the secondary orbital lesions, originating from the adjacent structure (eyelids, paranasal sinuses, nasopharynx &amp; cranial cavity), lesions of the haemopoitic reticuloendothelial system lesions and metastatic lesions.</p><p>Amongst the primary orbital lesions, retinoblastoma, nonspecific inflammations, fungal and tuberculous granulomas, pseudotumours, dermoid cysts, adenocystic carcinoma &amp; pleomorphic adenoma of lacrimal gland, cavernous haemangioma, optic nerve Glioma and meningioma, neurofibroma, rhabdomyosarcoma are the common orbital lesions. Amongst secondary orbital lesions, squamous cell carcinoma of the eyelid, chronic eth- moiditis and maxillary antrum carcinoma are the common lesions. Lymphomas/leukemias are also seen in good percentage in reticuloendothelial system lesions whereas metastatic lesions are very uncommon.</p></sec><sec id="s6"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.57203-ref1"><label>1</label><mixed-citation publication-type="book" xlink:type="simple">Lemke, B.N. and Lucarelli, M.J. (2012) Anatomy of the ocular Adnexa, Orbit and Related Facial Structures. In: Black, E.H., Nesi, F.A., Gladstone, G.J. and Levine, M.R., Eds., Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery, 3rd Edition, Springer Science + Business Media, LLC, New York, 3-58.  
http://dx.doi.org/10.1007/978-1-4614-0971-7_1</mixed-citation></ref><ref id="scirp.57203-ref2"><label>2</label><mixed-citation publication-type="book" xlink:type="simple">Costin, B.R., Perry, J.D. and Foster, J.A. (2014) Classification of Orbital Tumors. In: Perry, J.D. and Singh, A.D., Eds., Clinical Ophthalmic Oncology, Springer-Verlag, Berlin Heidelberg, 9-14.  
http://dx.doi.org/10.1007/978-3-642-40492-4_2</mixed-citation></ref><ref id="scirp.57203-ref3"><label>3</label><mixed-citation publication-type="book" xlink:type="simple">Rootman, J. and Nugent, R.A. (2003) Structure of the Orbit: Anatomic and Imaging Features. In: Rootman, J., Ed., Diseases of the Orbit: A Multidisciplinary Approach, 2nd Edition, Lippincott, Williams and Wilkins, Philadelphia, 1-15.</mixed-citation></ref><ref id="scirp.57203-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Khan, A.A., Amjad, M., Azher, A.N. and Sarwar, M.S. (1998) Orbital Lesions in Children. Pakistan Journal of Ophthalmology, 14, 86-89.</mixed-citation></ref><ref id="scirp.57203-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Parashkevova, B. and Balabanov, C. (2007) Orbital Tumors—Clinical Cases Presentation. Journal of IMAB—Annual Proceeding (Scientific Papers), 13, Book 1.</mixed-citation></ref><ref id="scirp.57203-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Demirci, H., Shields, C.L., Shields, J.A., Honavar, S.G., Mercado, G.J. and Tovilla, J.C. (2002) Orbital Tumors in the Older Adult Population. Ophthalmology, 109, 243-248. http://dx.doi.org/10.1016/S0161-6420(01)00932-0</mixed-citation></ref><ref id="scirp.57203-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Bonavolontà, G., Strianese, D., Grassi, P., Comune, C., Tranfa, F., Uccello, G. and Iuliano, A. (2013) An Analysis of 2,480 Space-Occupying Lesions of the Orbit from 1976 to 2011. Ophthalmic Plastic and Reconstructive Surgery, 29, 79-86. http://dx.doi.org/10.1097/IOP.0b013e31827a7622</mixed-citation></ref><ref id="scirp.57203-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ohtsuka, K., Hashimoto, M. and Suzuki, Y. (2005) A Review of 244 Orbital Tumors in Japanese Patients during a 21-Year Period: Origins and Locations. Japanese Journal of Ophthalmology, 49, 49-55.  
http://dx.doi.org/10.1007/s10384-004-0147-y</mixed-citation></ref><ref id="scirp.57203-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Angotti Neto, H., Cunha, L.P., Gasparin, F., Santo, R.M. and Monteiro, M.L. (2008) Orbital Space-Occupying Lesions: an 11-Year Study of Cases with Histopathologic Analysis Seen at Hospital das Clínicas of FMUSP. Arquivos Brasileiros de Oftalmologia, 71, 809-812. http://dx.doi.org/10.1590/S0004-27492008000600008</mixed-citation></ref></ref-list></back></article>